SBIR/STTR Research Award

SCIENTIFIC TESTING OF NMR STRUCTURE DETERMINATION SCHEME

Award identifier 931a9ff01dd268b7b46da669dbe5cb962ff8d767d99c253486784eaae57357f4Awarding agency Department of Health and Human Services

Award amount

$49,963

Program and phase

SBIR · Phase I

Award year

1991

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Biosym Technologies Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE OBJECTIVE OF THIS GRANT IS TO CARRY OUT THE SCIENTIFIC TESTING ASSOCIATED WITH A NEW NMR SOFTWARE PACKAGE DEVELOPED CURRENTLY AT BIOSYM, NAMELY AN INTEGRATED THEORETICAL/COMPUTATIONAL TOOL FOR DETERMINING MOLECULAR STRUCTURES FROM NMR DATA. THE SCHEME COMBINES AN ELABORATE NMR RELAXATION MATRIX APPROACH (IRMA) WITH VARIOUS MOLECULAR MODELING FORMULATIONS SUCH AS DISTANCE GEOMETRY (DG), RESTRAINED MOLECULAR DYNAMICS (RMD)/RESTRAINED ENERGY MINIMIZATION (REM) AND DYNAMICAL SIMULATED ANNEALING (DSA). STRUCTURE DETERMINATION PROCEEDS BY FIRST \GENERATING' A STRUCTURE, WITH AN EXTENDED VERSION OF T. HAVEL'S METRIC MATRIX FORMULATION CALLED DG II OR WITH A RECENTLY PROPOSED DSA SCHEME, WHICH HAS BEEN IMPLEMENTED AT BIOSYM USING THE MOLECULAR DYNAMICS (MD) PACKAGE DISCOVER. THIS IS FOLLOWED BY STRUCTURE REFINEMENT, PURSUED USING A DISCOVER-INTEGRATED VERSION OF IRMA. THE INTEGRITY AND VALIDITY OF THIS COMPLEX SYSTEM IS CONTINGENT UPON CAREFUL SCIENTIFIC TESTING AIMED AT ASSESSING LIMITATIONS (ON ONE HAND) AND RELATIVE ADVANTAGES OF ALTERNATIVE COMPONENTS (ON THE OTHER). MOREOVER, THE UNIQUE SCIENTIFIC RIGOR INHERENT IN THIS SYSTEM WILL BE FULLY APPRECIATED ONLY IF WE CAN ILLUSTRATE ITS ABILITY TO SOLVE MOMENTARILY AMBIGUOUS MOLECULAR STRUCTURES. DG II AND THE DISCOVER-BASED DSA WILL BE EVALUATED COMPARATIVELY USING CRAMBIN AS A TEST CASE. LIMITATIONS AND BENEFITS OF THE TWO TECHNIQUES WILL BE PINPOINTED BY SUBJECTING BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) TO A DETAILED INVESTIGATION AND COMPARING THE RESULTS WITH PREVIOUS STUDIES. A SENSITIVITY TEST OF IRMA WILL BE PERFORMED USING THE ALPHA-AMYLASE INHIBITOR TENDAMISTAT. THE IMPORTANT IMPLICATIONS OF TREATING INTERNAL MOTIONS, TO THE EXTENT THAT PREVIOUS STRUCTURAL AMBIGUITIES CAN BE RESOLVED BY PROPERLY ACCOUNTED FOR DYNAMIC PHENOMENA, WILL BE ILLUSTRATED BY RE-INVESTIGATING NEUTROPHIL PEPTIDE 5. THE MERIT OF THIS RESEARCH IN TERMS OF TECHNOLOGICAL INNOVATION AND COMMERCIAL VALUE WILL BE BORNE OUT BY A SCIENTIFICALLY SOUND, NOVEL, UNIQUE AND VERY USEFUL TOOL FOR ELUCIDATING NMR STRUCTURES.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.